
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Cue Biopharma, a clinical-stage biopharmaceutical company, is developing a novel class of injectable biologics to selectively engage and modulate disease-specific T cells directly within the patients body. The companys proprietary platform, Immuno-STATTM (Selective Targeting and Alteration of T cells) and biologics are designed to harness the bodys intrinsic immune system as T cell engagers without the need for ex vivo manipulation or broad systemic immune modulation
Cue biopharma operates in the Biotechnology research industry.
Cue biopharma's revenue is 11m - 100m
Cue biopharma has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.